Loading...
Journey Medical Community
NasdaqCM:DERM Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
Community Investing Ideas
Rising Global Dermatologic Demand Will Fuel Future Success
Key Takeaways Rapid adoption of EMROSI and expanded insurance coverage are driving strong revenue growth and positioning the company to benefit from increased dermatology demand. Financial discipline and operational leverage support profitability while mitigating risks from legacy products, enhancing earnings resilience and reducing potential dilution.Read more
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
US$13.5
44.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
46.96% p.a.
Profit Margin
37.74%
Future PE
7.66x
Share price in 2028
US$9.16
